DoW Rare Cancers Idea Development Award
Open. Closes November 18, 2026, 27 days from October 22, 2026, as posted on Grants.gov. Posted by Defense Health Agency Contracting Activity - DHACA, opportunity number HT942526RCRPIDA.
Get a first draft in your own AI assistant
Free, no account. Add CedarGrant to Claude, then paste this into a new chat. Your assistant reads the official notice, asks you a few questions and writes a first draft in the notice's format.
Use CedarGrant to help me apply for DoW Rare Cancers Idea Development Award (HT942526RCRPIDA): https://simpler.grants.gov/opportunity/362849
Already writing? Paste this instead, with your draft attached:
Use CedarGrant to make a Requirements Map and run a Reviewer Panel on my draft for HT942526RCRPIDA.
Notice facts
| Agency | Defense Health Agency Contracting Activity - DHACA |
|---|---|
| Opportunity number | HT942526RCRPIDA |
| Assistance listing | 12.420 |
| Funding instrument | Grant |
| Category | Science and Technology and other Research and Development |
| Posted | June 17, 2026 |
| Closes | November 18, 2026 |
| Award range | Not stated |
| Expected number of awards | 15 |
| Total program funding | $7,350,000 |
| Cost sharing or matching | Not required, per the notice |
| Applicant types listed | Unrestricted (any type of organization, subject to the notice's eligibility text) |
| Additional eligibility information | None listed |
| Where to apply | Check the notice for where and how to submit. |
As posted on Grants.gov, checked October 21, 2026. CedarGrant lists what the notice states; it does not judge whether an organization is eligible. The official notice and its modifications control.
Summary from the notice
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation. Distinctive Features: The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research. Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study. Research should…
Official notice and documents
- HT942526RCRPIDA_GG.pdf (Full Announcement)
Similar open grants
| Closes | Grant | Agency | Award range |
|---|---|---|---|
| October 22, 2026 0 days left | DoW Arthritis Clinical Research Award | Defense Health Agency Contracting Activity - DHACA | Not stated |
| October 22, 2026 0 days left | DoW Arthritis Translational Research Award | Defense Health Agency Contracting Activity - DHACA | Not stated |
| October 22, 2026 0 days left | DoW Autism Career Development Award | Defense Health Agency Contracting Activity - DHACA | Not stated |
| October 22, 2026 0 days left | DoW Autism Clinical Trial Award | Defense Health Agency Contracting Activity - DHACA | Not stated |
| October 22, 2026 0 days left | DoW Autism Idea Development Award | Defense Health Agency Contracting Activity - DHACA | Not stated |